Awards for “BRISTOL-MYERS SQUIBB COMPANY”
25 awards on this page · sorted by amount · page 1
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| 36C25226N0198 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $848.45K | 2025-12-31 | 2026-10-31 | 325412 | REVLIMID, POMALYST, CAMZYOS SPECIALTY PHARMACEUTICALS |
| 36C24825N0730 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $670.09K | 2025-05-15 | 2025-09-14 | 325412 | EMERGENCY BREYANZI INFUSION |
| 36C24926N0651 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $378.65K | 2026-08-10 | 2026-11-09 | 325412 | ABECMA INJECTION |
| 36C24926F0096 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $378.65K | 2026-03-13 | 2026-09-12 | 325412 | ABECMA FOR CAR-T |
| 36C24526N0290 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $365.12K | 2026-01-29 | 2026-09-30 | 325412 | MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST) |
| 36C24926N0658 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $364.14K | 2026-09-11 | 2026-12-14 | 325412 | BREYANZI INJECTION |
| 36C26226N0738 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $364.14K | 2026-06-30 | 2026-09-30 | 325412 | EMERGENCY BREYANZI |
| 36C24926N0591 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $364.14K | 2026-06-18 | 2026-09-17 | 325412 | BREYANZI CAR T - TRANSPLANT |
| 36C24926N0590 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $364.14K | 2026-06-18 | 2026-09-17 | 325412 | BREYANZI CAR T - TRANSPLANT |
| 36C24926N0589 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $364.14K | 2026-06-18 | 2026-09-17 | 325412 | BREYANZI CAR T |
| 36C24926N0433 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $364.14K | 2026-06-02 | 2027-06-01 | 325412 | BREAYNAZI FOR CAR-T TRANSPLANT MEDICATION |
| 36C24926N0543 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $364.14K | 2026-06-22 | 2026-09-25 | 325412 | BREYANZI CAR-T |
| 36C24926N0528 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $364.14K | 2026-06-26 | 2026-09-30 | 325412 | BREYANZI CAR-T TRANSPLANT. |
| 36C24926N0526 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $364.14K | 2026-06-11 | 2026-09-01 | 325412 | BREYANZI CAT-T TRANSPLANT |
| 36C24926F0137 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $364.14K | 2026-05-29 | 2026-08-31 | 325412 | BREYANZI CAR T-TRANSPLANT |
| 36C24926N0244 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $338.93K | 2025-12-05 | 2026-03-04 | 325412 | ABECMA TRANSPLANT DRUG |
| 36C24926N0219 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $338.93K | 2025-10-09 | 2026-01-08 | 325412 | ABECMA FOR CAR-T |
| 36C24925N0740 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $338.93K | 2025-09-15 | 2025-12-14 | 325412 | ABECMA CAR T FOR TRANSPLANT |
| 36C24925N0652 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $338.93K | 2025-08-11 | 2025-11-10 | 325412 | ABECMA CAR T |
| 36C24925N0643 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $338.93K | 2025-07-23 | 2025-09-22 | 325412 | QTY:1, ABECMA INJECTION FOR CART T TRANSPLANT |
| 36C24925N0539 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $338.93K | 2025-05-29 | 2025-07-28 | 325412 | ABECMA FOR TRANSPLANT |
| 36C24925N0522 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $338.93K | 2025-06-16 | 2025-08-15 | 325412 | ABECMA INJECTIONS NEEDED |
| 36C24925N0411 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $338.93K | 2025-03-18 | 2025-05-17 | 325412 | ABECMA TRANSPLANT INJECTION |
| 36C24925N0379 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $338.93K | 2025-03-01 | 2025-04-30 | 325412 | TRANSPLANT DRUG |
| 36C24926N0286 | BRISTOL-MYERS SQUIBB COMPANY | Department of Veterans Affairs | $335.04K | 2026-01-21 | 2026-04-30 | 325412 | BREYANZI CAR T CELL THERAPY |